Esperion Therapeutics, Inc(NASDAQ:ESPR) 
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low-density lipoprotein cholesterol in the United States and internationally. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic aci...
Website: http://www.esperion.com
Founded: 1998
Full Time Employees: 193
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 1.28
H 1.30
L 1.17
C 1.23
V 5,323,118
10EMA 1.23
20EMA 1.23
60EMA 1.23
120EMA 1.23
250EMA 1.23